[IgA vasculitis with necrosis of the small intestine secondary to monoclonal gammopathy of renal significance: A case report]. [PDF]
Ding Y +7 more
europepmc +1 more source
[Expert consensus on the comprehensive management of monoclonal gammopathy of undetermined significance and smoldering multiple myeloma in China (2025)]. [PDF]
Plasma Cell Disease Group +3 more
europepmc +1 more source
Olig2+ single-colony-derived cranial bone-marrow mesenchymal stem cells achieve improved regeneration in a cuprizone-induced demyelination mouse model. [PDF]
Peng D +8 more
europepmc +1 more source
应用单克隆抗体3A1-柔红霉素结合物(3A1-DM)临床治疗8例急性T淋巴细胞白血病患者。经初步验证,鼠源性单克隆抗体制备的导向药物输入人体内未发生严重过敏反应与毒副作用。疗程完毕后,以骨髓象为标准评价临床治疗效果,获完全缓解者3/8例(37.5%),部分缓解4/8例(50%),无效1/8例(12.5%)例,总有效率达87.5%。初步验证了微量导向药物在临床治疗中的效果。
doaj
131I-Anti-c-erb2 免疫导向治疗卵巢癌的实验研究
【目的】观察放射性核素标记针对癌蛋白为靶点的单克隆抗体载体外对卵巢癌细胞的抑制作用。【方法】应用氯胺T法将131I和抗c-erb2单克隆抗体标记,取不同浓度的131I-Anti-c-erb2与SKOV3细胞共同培养,MTT法检测其对SKOV3细胞生长的抑制作用。【结果】体外单抗浓度为22.20mg/L时,131I-Anti-c-erb2的相对抑制率为64.85%,可以明显抑制SKOV3细胞,未标记的抗c-erb2单抗的相对抑制率为3.40%,对SKOV3细胞的生长几乎没有抑制作用。【结论】131I ...
doaj
[Clinical characteristics, treatment, and prognosis of double-hit multiple myeloma with concurrent 1q21+ and t (4;14)]. [PDF]
Guo Y +8 more
europepmc +1 more source
[Advances in targeted therapies for chronic spontaneous urticaria]. [PDF]
Zhou L, Hu C, Wang S, Zhang R.
europepmc +1 more source
[Indolent γδT-cell clone in Felty syndrome: a case report and literature review]. [PDF]
Wang C, Fu MW, An G, Huang WY, Yang LJ.
europepmc +1 more source
[High-throughput sequencing in identifying somatic hypermutation in immunoglobulin heavy chain variable regions with complex clonal backgrounds]. [PDF]
Gao MG +5 more
europepmc +1 more source
[Chronic myelomonocytic leukemia complicated with T-lymphoblastic lymphoma: a case report and literature review]. [PDF]
Yang YZ, Xu WY, Jiao YJ, Guo ZX.
europepmc +1 more source

